Concepedia

Anita Mathias

AM

Statistics

Publications

45

Citations

3K

H-Index

29

Active since

2004

Affiliations

Gilead Sciences (United States)(Current)

University of Washington

Bristol-Myers Squibb (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Orlando Clinical Research Center

Anita Mathias is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2004–2021

45

Publications

45

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Kenneth H. Mayer, Jean‐Michel Molina, Melanie Thompson et al. · The Lancet · 2020 · 409 citations · Full text

, , +10

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects

Rita Humeniuk, Anita Mathias, Huyen Cao et al. · Clinical and Translational Science · 2020 · 261 citations · Full text

Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity

Anita Mathias, Polina German, Bernard P. Murray et al. · Clinical Pharmacology & Therapeutics · 2009 · 206 citations

P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages

Anita Mathias, Jane Hitti, Jashvant D. Unadkat · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2005 · 185 citations

, , +11

Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function

Polina German, Hui C. Liu, Javier Szwarcberg et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2012 · 164 citations

Rows per page

1–5 of 45